<code id='558ECAB56D'></code><style id='558ECAB56D'></style>
    • <acronym id='558ECAB56D'></acronym>
      <center id='558ECAB56D'><center id='558ECAB56D'><tfoot id='558ECAB56D'></tfoot></center><abbr id='558ECAB56D'><dir id='558ECAB56D'><tfoot id='558ECAB56D'></tfoot><noframes id='558ECAB56D'>

    • <optgroup id='558ECAB56D'><strike id='558ECAB56D'><sup id='558ECAB56D'></sup></strike><code id='558ECAB56D'></code></optgroup>
        1. <b id='558ECAB56D'><label id='558ECAB56D'><select id='558ECAB56D'><dt id='558ECAB56D'><span id='558ECAB56D'></span></dt></select></label></b><u id='558ECAB56D'></u>
          <i id='558ECAB56D'><strike id='558ECAB56D'><tt id='558ECAB56D'><pre id='558ECAB56D'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:focus    Page View:437
          Adobe

          The Biden administration moved Wednesday to force insurance companies to give specific reasons for denying coverage, and to speed up the pre-approval process in general.

          The new rule applies to health insurance companies that offer Medicare, Medicaid, Children’s Health Insurance Program, and Obamacare plans. It concerns so-called prior authorization requests, and will require insurers to return urgent requests within 72 hours and non-urgent requests within seven days.

          advertisement

          The changes are a win for patients seeking care, but also for health care providers like hospitals and physicians. Executives from California-based Sutter Health, Massachusetts General Brigham, and others repeatedly cited the rise in insurer denials since the pandemic at last week’s J.P. Morgan Healthcare conference.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Apellis safety probe of eye disease drug centers on injection needle
          Apellis safety probe of eye disease drug centers on injection needle

          AlexHogan/STATApellisPharmaceuticalssaidTuesdaythatithadidentified“internalstructuralvariations”inat

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          FDA greenlights medical device to combat bladder issues

          AndrewHarnik/APYou’rereadingthewebeditionofSTATHealthTech,ourguidetohowtechistransformingthelifescie